OncoNext® Risk includes the study of germline mutations, carriers of these mutations have higher predisposition of developing tumor pathologies. 

OncoNext™ Risk OncoScreening Complete (includes all Onconext™Risk panels). This diagnostic test allows to evaluate the predisposition to different hereditary tumor types (please find below the list of genes):